This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Daiichi Sankyo Company, Limited. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Kotaro Kawanami: Innovator in Thrombotic Disease Treatment
Introduction
Kotaro Kawanami is a notable inventor based in Edogawa, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that can aid in the treatment of thrombotic diseases. His work is characterized by a focus on innovative processes that enhance the efficacy of therapeutic agents.
Latest Patents
Kawanami holds a patent for an "Optically active diamine derivative and process for producing the same." This invention is directed towards a process for producing intermediates of a compound that exhibits an activated blood coagulation factor Xa inhibitory action. This compound is recognized as a useful preventive and therapeutic agent for thrombotic diseases. The intermediate production process is represented by a specific reaction scheme that Kawanami has developed.
Career Highlights
Kawanami is currently associated with Daiichi Sankyo Company, Limited, where he continues to advance his research and development efforts. His work has been instrumental in creating innovative solutions that address critical health issues related to blood coagulation and thrombotic conditions.
Collaborations
Throughout his career, Kawanami has collaborated with esteemed colleagues, including Koji Sato and Tsutomu Yagi. These collaborations have fostered a productive environment for innovation and have contributed to the success of their joint research endeavors.
Conclusion
Kotaro Kawanami's contributions to the field of medicinal chemistry, particularly in the area of thrombotic disease treatment, highlight his role as a significant inventor. His innovative processes and collaborative efforts continue to pave the way for advancements in therapeutic agents.